M4MM
Clampdown on Australian Medicinal Cannabis Prescribing Raises Questions on Effectiveness
LOS ANGELES- Health regulators in Australia recently issued reinforced guidance aimed at improving prescribing standards for medicinal cannabis, reflecting growing concerns over patient safety and industry conduct. The Australian Health Practitioner Regulation Agency (AHPRA), along ...
The Senator Who Legalized Consumable Hemp Now Wants to Ban It
WASHINGTON, D.C.–Senator Mitch McConnell (R-KY), once hailed as the architect of federal hemp legalization under the 2018 Farm Bill, is now backing efforts that could dismantle the very market he helped create. Industry insiders say ...
Canadian Court Sides with Psychedelic Therapy Advocates in Psilocybin Exemption Case
LOS ANGELES- A Canadian federal court has ordered Health Canada to revisit its denial of psilocybin exemptions for health-care professionals, marking a significant development in the country’s evolving drug policy landscape. The ruling stems from ...
Glass House Brands to Manage The Leaf El Paseo Dispensary
LOS ANGELES- Glass House Brands Inc. and LEEF Brands Inc. have entered into a Management Services Agreement (MSA), under which Glass House will oversee operations of The Leaf El Paseo dispensary in Palm Desert, California. ...
Pennsylvania Senate Committee Rejects Cannabis Legalization Bill
LOS ANGELES- In a recent development, the Pennsylvania Senate Law and Justice Committee voted 7-3 against House Bill 1200, a proposal aimed at legalizing adult-use cannabis in the state. This decision follows the bill's narrow ...
Humboldt Family Farms: The Science of Natural Light
In the lush tapestry of cannabis cultivation, the sun shines like a master artist, painting each plant with strokes of light that define its essence. The embrace of natural sunlight not only stimulates the growth ...
atai Life Sciences Initiates Phase 2 Trial of EMP-01 for Social Anxiety Disorder
LOS ANGELES- atai Life Sciences has commenced a Phase 2 clinical trial evaluating EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine (R-MDMA), for the treatment of social anxiety disorder (SAD). The first patient has been dosed in ...
Clampdown on Australian Medicinal Cannabis Prescribing Raises Questions on Effectiveness
LOS ANGELES- Health regulators in Australia recently issued reinforced guidance aimed at improving prescribing standards for medicinal cannabis, reflecting growing concerns over patient safety and industry conduct. The Australian Health Practitioner Regulation Agency (AHPRA), along ...
The Senator Who Legalized Consumable Hemp Now Wants to Ban It
WASHINGTON, D.C.–Senator Mitch McConnell (R-KY), once hailed as the architect of federal hemp legalization under the 2018 Farm Bill, is now backing efforts that could dismantle the very market he helped create. Industry insiders say ...
Canadian Court Sides with Psychedelic Therapy Advocates in Psilocybin Exemption Case
LOS ANGELES- A Canadian federal court has ordered Health Canada to revisit its denial of psilocybin exemptions for health-care professionals, marking a significant development in the country’s evolving drug policy landscape. The ruling stems from ...
The Rise and Debate of Delta-8 THC: Understanding the Controversy
LOS ANGELES- Delta-8-Tetrahydrocannabinol (delta-8 or ∆8-THC) is making headlines as its popularity soars, primarily due to federal regulations that ambiguously classify it. Resembling the more commonly known Delta-9-Tetrahydrocannabinol in structure and effect, this lesser-known cannabinoid ...
Aurora Cannabis Settles Patent Litigation with Willow Biosciences
TORONTO — Aurora Cannabis, the Alberta-based licensed producer, has finalized a confidential settlement with Willow Biosciences over a previously ongoing patent litigation that began in July 2021. The specific terms and conditions of the settlement ...
Cybin Inc. and Small Pharma Join Forces in a Milestone Psychedelic Therapeutics Acquisition
LOS ANGELES- In a notable merger move in the psychedelic therapeutics landscape, Small Pharma Inc. has received the green light from the Supreme Court of British Columbia for its acquisition by Cybin Inc. This all-stock ...
4Front Ventures Secures Credit Agreement, Issues RSUs
PHOENIX — 4Front Ventures Corp., a prominent multi-state cannabis operator and retailer, declared on [Date] the issuance of restricted stock units (RSUs) linked to its newly established $10-million senior secured credit facility agreement. The Phoenix-based ...
Major Corporations Lobby for Cannabis Banking Reforms
NEW YORK — An analysis of recent Congressional lobbying disclosures has unveiled that prominent corporations like Bank of America, Mastercard, and GlaxoSmithKline, among others, are now lobbying for cannabis banking reform. The spotlight has been ...
Ayr Wellness Dispensary in Las Vegas Joins Growing Trend of Cannabis Unionization
LAS VEGAS — Workers at a Las Vegas cannabis store, known as The Dispensary and operating under the Ayr Wellness brand, have elected to unionize with the United Food and Commercial Workers Union (UFCW) Local ...
FSD Pharma and Celly Nutrition Corp. Schedule Virtual Securityholders Meeting
TORONTO — FSD Pharma, a noted biopharmaceutical company, and its partner Celly Nutrition Corp. have jointly announced a virtual meeting for FSD Pharma's securityholders. Slated for November 20, 2023, at 1:00 p.m. Toronto time, this ...
House VA Subcommittee Postpones Historic Psychedelic-Assisted Therapy Hearing
LOS ANGELES- A groundbreaking hearing of the House VA’s subcommittee on Health, set to discuss the potential of psychedelic-assisted therapies in combating mental health disorders, has been postponed. The delay was attributed to the ongoing ...
Higher Collective Elevates Connecticut’s Cannabis Landscape with Equity Ventures
LOS ANGELES- Connecticut's budding cannabis sector witnessed a significant milestone earlier this month as Higher Collective, a venture committed to fostering inclusivity and equity in the industry, unveiled its debut dispensary in Killingly on October ...
PharmaDrug Announces Share Consolidation and Appoints New CFO
LOS ANGELES — PharmaDrug Inc, a pharmaceutical company, has made two significant announcements today. Firstly, it has detailed its upcoming share consolidation, and secondly, it has named a new Chief Financial Officer. Beginning October 24, ...
InterCure Responds to Israeli Security Crisis: Operations Impact and Company Commitment Highlighted
TEL AVIV — InterCure Ltd., operating as Canndoc, a medical cannabis firm in Israel and globally outside North America, today addressed the recent security situation in Israel and its repercussions on the company's operations ...
Tilray and Docklight Settle Dispute Over Bob Marley-Branded Cannabis Product Deal
LOS ANGELES- A legal battle between Tilray Brands Inc. and Docklight Brands concerning an agreement to market Bob Marley-branded cannabis products in Canada has come to a close. U.S. District Judge Tana Lin, located in ...
New York’s Legal Cannabis Sales Reach $83 Million in 2023
NEW YORK — Recreational cannabis sales in New York have hit the $83 million mark from the onset of 2023 through September 29, based on the latest preliminary data provided by the state's cannabis regulatory ...
Revive Therapeutics Partners with Canadian Defence Agency on Nerve Agent Treatment Research
TORONTO — Revive Therapeutics Ltd., a specialty life sciences firm dedicated to developing treatments for rare disorders and medical needs, announced today its collaboration with Defence R&D Canada – Suffield Research Centre (DRDC), an entity ...
Pharmaceutical Industry Faces Record-High Settlements Over a Decade, Report Shows
NEW YORK — A recent report has brought to light staggering numbers concerning financial settlements and penalties within the pharmaceutical sector. Published on Oct. 17 by ConsumerShield, the report reveals that over the past decade, ...
